drugset / Trial / NCT01513525

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

NCT01513525

Phase 1 Completed 21 enrolled Novo Nordisk A/S
RandomizedCrossoverOpen-labelTreatment

Summary

This trial is conducted in Europe. the aim of this trial is to compare the pharmacokinetic profile of liraglutide between administrations in the thigh versus the abdomen and between administrations in the upper arm versus the abdomen.

Timeline

Start
2007-02
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Liraglutide Peptide 0.6 mg Subcutaneous

Indications